Related Experiment Video
Updated: Apr 18, 2026

07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
35.3K
Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissue
J G Baust1, J C Bischof2, S Jiang-Hughes2
11] Institute of Biomedical Technology, State University of New York at Binghamton, Binghamton, NY, USA [2] Department of Biological Sciences, Binghamton University, Binghamton, NY, USA.
Prostate Cancer and Prostatic Diseases
|January 28, 2015
Summary
Cryoablation (CA) offers a unique approach to cancer treatment by inducing cell death through physical and molecular damage. This method disrupts cancer
Area of Science:
- Oncology
- Cancer Biology
- Therapeutic Modalities
Background:
- The tumor microenvironment shields cancer cells, promoting resistance to therapies like chemotherapy and radiotherapy.
- Repeated treatments allow cancer cells to evolve resistance mechanisms, such as secreting protective proteins.
- Effective cancer management necessitates activating multiple cell death pathways to overcome these adaptations.
Purpose of the Study:
- To review the application and clinical outcomes of cryoablation (CA) in cancer treatment.
- To emphasize the diverse mechanisms of cell death induced by CA.
- To explore how CA can be a combinatorial treatment modality.
Main Methods:
- Review of existing literature on cryoablation (CA) applications and outcomes.
- Analysis of CA's cell death mechanisms, including structural, metabolic, vascular, and immune processes.
- Discussion of how CA induces apoptosis and necrosis.
Main Results:
- Cryoablation (CA) acts as a unique monotherapy, preventing cancer cell adaptation and resistance.
- CA induces cell death through physical and molecular insults, independent of the cell cycle.
- CA triggers diverse cell death cascades, including apoptosis and necrosis.
Conclusions:
- Cryoablation (CA) functions as a combinatorial treatment by inducing multiple cell death pathways.
- The mechanisms of CA support its use in combination with other therapies to enhance cell death.
- Understanding CA's cell death induction facilitates the development of adjunctive treatment strategies.

